Premium
The 2‐week wait and other initiatives to improve cancer diagnosis: Has it altered survival? The answer is unclear—the evidence is too weak
Author(s) -
Bankhead C.
Publication year - 2017
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.12712
Subject(s) - medicine , cancer survival , cancer , overall survival , stage (stratigraphy) , intensive care medicine , oncology , paleontology , biology
The UK is one of the lowest ranked high‐income countries for cancer survival. Later stage at diagnosis is a significant contributor to reduced survival. Several strategies have been introduced to reduce delays in an effort to diagnose cancer earlier. This commentary summarises the evidence and impact of these initiatives.